Earnings call transcript: Bank Rakyat Indonesia Q1 2026 results

Bank Rakyat Indonesia’s Q1 2026 results were mixed but broadly solid: revenue beat estimates at 52.84 trillion IDR versus 52.38 trillion IDR expected, while EPS missed slightly at 103 IDR versus 104.08 IDR forecast. Loan growth was strong at 13.7% year-on-year, total assets rose 7.2%, and NIM reached 7.9%, above guidance, though management kept a cautious stance on 2026 due to macro and geopolitical risks. The stock rose 1.34% to 2,990 IDR after earnings, and the bank reaffirmed a 2.9%-3.2% cost of credit outlook and a continued high dividend profile.

Analysis

The core takeaway is not the modest earnings miss; it is that BBRI is re-rating from a balance-sheet cleanup story into a funding-mix and operating-leverage story. When a bank with structurally high NIM keeps deposit costs anchored while growing CASA faster than loans, the earnings power is less cyclical than headline credit anxiety suggests. That tends to benefit the whole Himbara ecosystem: better transaction velocity, stronger cross-sell, and lower marginal funding costs create a wider moat versus smaller Indonesian banks that still rely more heavily on term deposits.

The second-order effect is that the market is likely underestimating how much of the current asset-quality drag is a timing issue rather than a regime break. The portfolio cleanup in legacy micro and consumer books should create an earnings inflection over the next 2-4 quarters as old vintages roll off and new underwriting standards season in. The key risk is that this improvement can be interrupted by macro shock transmission through fuel prices and FX weakness, which would first hit lower-income borrowers and then show up as slower recovery income, higher provisioning, and weaker loan appetite before it hits reported NPLs.

Consensus is probably over-indexing on the dividend yield as if it were pure downside protection. In reality, the payout is becoming a capital-allocation variable, and management is explicitly signaling willingness to flex dividend if macro worsens; that makes the stock less bond-like than the headline yield implies. The contrarian setup is that if credit costs merely stay inside guidance while funding costs stabilize, the market has room to re-rate BBRI on sustainable ROE rather than peak yield, especially if the consumer/gold engines begin contributing higher-quality fee income rather than just loan growth.

Key Decisions for Investors

• Long BBRI vs. short BMRI for 3-6 months: BBRI has the clearer operating leverage from CASA and digital engagement, while BMRI is more exposed to policy/wholesale funding noise. Target relative outperformance if BBRI holds NIM above guidance and CoC stays contained.
• Buy BBRI common on pullbacks near local support for a 2-4 quarter horizon; pair with a stop if macro stress pushes deposit costs higher or if guidance is cut. Risk/reward favors owning a bank where earnings are being revised by mix improvement, not just loan growth.
• Sell out-of-the-money downside puts on BBRI with 3-6 month tenor to monetize elevated dividend-linked implied support. This is best only if you can tolerate assignment; the thesis breaks if oil/FX shock forces a funding-cost reset.
• For a hedge, short smaller Indonesian banks with weaker CASA franchises against long BBRI. The relative trade expresses the view that transaction banking and digital stickiness will widen the cost-of-funds gap over the next two quarters.
• Monitor for a post-earnings rally fade in the next 2-3 weeks; if the stock fails to reclaim pre-gap levels, trim rather than add. The easy upside is already in the print, and the next catalyst needs proof of asset-quality inflection, not just narrative.